CO23 is a selective thyroid hormone receptor alpha (TRα) agonist used to regulate growth and development; it reduces cholesterol levels by approximately 50% at a dose of 0.8 nmol/g (with higher doses showing similar efficacy) and upregulates Dio1 mRNA expression in a dose-dependent manner (5-, 10-, and 15-fold increases at 0.8, 2.5, and 5 nmol/g, respectively); it is also capable of crossing the blood-brain barrier.